ZEVRA THERAPEUTICS, INC. Annual Costs and Expenses in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Zevra Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to 2023.
  • Zevra Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $23.1M, a 64.6% increase year-over-year.
  • Zevra Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $92.5M, a 82.2% increase year-over-year.
  • Zevra Therapeutics, Inc. annual Costs and Expenses for 2023 was $77.1M, a 46.2% increase from 2022.
  • Zevra Therapeutics, Inc. annual Costs and Expenses for 2022 was $52.7M, a 152% increase from 2021.
  • Zevra Therapeutics, Inc. annual Costs and Expenses for 2021 was $20.9M, a 10.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $77.1M +$24.3M +46.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $52.7M +$31.8M +152% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $20.9M +$2.02M +10.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $18.9M -$14.3M -43% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $33.2M -$22.7M -40.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $55.9M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.